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abnormalities. Others include chest wall pain,
myalgia and joint pain . Constitutional symptoms
such as fever, malaise, weight loss and night sweats
precede vascular complications by weeks or months .
Bruits over the subclavian artery, carotid and
abdomen may be present. Absent or reduced pulse
volume in one or more large arteries is detected and
blood pressure discrepancy of greater than 30 mmHg
between arms . With progression, cardiac symptoms
are prominent and massive haemoptysis indicates
pulmonary artery involvement . Neurological
symptoms are present in 80% of patients with
Takayasu's disease that involves the brachiocephalic
arteries .
Four late-phases of Takayasu's disease have been
described on the basis of the sites of vessel
involvement : they are type 1- classic pulseless type
that involves the brachiocephalic trunk, carotid
arteries, and the subclavian arteries. Type 2 which is a
combination of type 1 and 3. Type 3- atypical
coarctation, type that involves the thoracic and
abdominal aortas distal to the arch and its major
branches. Type 4-dilated type that involves extensive
dilatation of the length of the aorta and its major
branches.
The most common type is the type 3, which is found
in as many as 65% of patients. The most commonly
involved vessels include the left subclavian artery
(50%), the left common carotid artery (20%), the
brachiocephalic trunk, the renal arteries, the celiac
trunk, the superior mesenteric artery, and the








Takayasu's disease was described by a Japanese
ophthalmologist in 1908. It is a primary vasculitis
affecting aortic arch and the major branches of the
aorta. The average age at diagnosis is in the mid
twenties, but the disease may begin as early as age
seven or as late as seventy years. It affects women
eight times more frequently than men.
Reports have linked Takayasu's disease with
infectious agents, including spirochetes, bacterial,
mycobacterial and viruses. There is no convincing
evidence that any of these play a pathogenetic role in
Takayasu's disease . Genetic studies remain
controvertial. Earlier studies had shown a
relationship with HLA-BW52 in Takayasu's disease
in Japanese patients . Other studies however did not
confirm the HLA-BW52 association .
The earliest change seems to be a granulomatous
inflammation in the adventitia and outer layers of the
affected arteries with gradual progression to a
panarteritis . Histology shows an infiltration of
lymphocytes , p lasma cel ls , h is t iocytes ,
multinucleated giant cells and occasional
polymorphonuclear cells with resultant disruption of
the normal architecture of the vessels .
Clinical features are of two groups: those due to
vascular damage and those due to systemic
inflammation. Presentations include hypertension,
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Takayusu's disease is a rare disease affecting women predominantly during the child- bearing
age. It is a primary vasculitis condition of large-vessels that responds well to steroid therapy.
Immunosuppressives and vascular reconstruction may be needed as necessary.
Reference was made to the case note of this young boy who was being co-managed by cardiology
and vascular clinics. The diagnosis of Takayasu's disease was confirmed by the rheumatology unit and
appropriate literature search was done.
Takayusu's disease responds well to steroid therapy as exemplified by this patient. There was no
relapse of the active inflammation after six months of steroid therapy.
A high index of suspicion must be exercise in diagnosing Takayasu's disease. It could be difficult
to have a clue early in the disease process because of non-specific presentations. Appropriate referral should
however be made to Rheumatologist when the diagnosis is suspected. This will go a long way in delaying the
morbidity that is associated with this rare disease.
Rheumatology Unit, Inkosi Albert Luthuli Central Hospital, Durban, South Africa
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failure. He is presently doing well on low dose
prednisolone.
Takayasu's disease was named after Japanese
ophthalmologist who first described the ocular
manifestation in 1908. It is also variously known by a
number of synonyms. These include pulseless
disease, aortic arch arteritis, non-specific
aortoarteritis and Takayasu's arteritis .
Takayasu's disease was said to be rare in the black
race. Underdiagnosis of the disease might have
accounted for this rarity. Ogunbiyi and Falase had
reported four cases, all women in the South West of
Nigeria . In 2003, Okeahialam et al also reported a
case in the Northern part of Nigeria .
Diagnosis of Takayasu's disease requires a high index
of suspicion. The American College of
Rheumatology has however proposed criteria useful
in the diagnosis of Takayasu's disease. The presence
of three out of six criteria is needed. This is said to be
91% sensitive and 98% specific for Takayasu's
disease .
The criteria met by this patient include age of onset
before 40 years, decreased brachial artery pulse,
unequal arm blood pressure, subclavian bruit and
angiographic evidence of occlusion of subclavian
artery on the left. The last criterion which was not
present in this patient is limb claudication.
This patient presented with minimal joint complaint.
Joint pain may however be severe but actual synovitis
is uncommon and where present is usually mild .
There was no ocular complaint in this patient, and
this is in agreement with the recent presentation of
Takayasu's disease. The ischaemic retinopathy that
was originally reported by Takayasu is very rare
today .
The symptoms of this patient were well controlled
with prednisolone without additional drugs. Some
patients will however in addition to Prednisolone
need immunosuppressive agents. The commonly
used immunosuppressives in Takayasu's disease are
methotrexate and mycophenolate mofetil .
This patient was in remission two months after the
commencement of high dose prednisolone.
Remission in Takayasu's disease is defined as
resolution of signs, symptoms, and laboratory
markers of inflammation as well as lack of
progression of angiographic abnormalities .
It is too early to determine the prognosis in this
patient. The fact however is that almost all patients
will experience morbidity from Takayasu's disease .
Because of the chronic relapsing and remitting nature
of this disease, a careful monitoring and adjustment
of therapy in this patient is necessary. Mortality is
caused by renal failure, stroke, cardiac failure, or











brachial, vertebral, coronary and the iliac arteries are
involved .
Laboratory findings are non-specific. Anaemia, mild
leucocytosis, elevated ESR (erythrocyte
sedimentation rate) and hypoalbuminaemia may be
detected in active inflammation . The diagnosis is
confirmed by arteriography. Other useful
investigations include CT scan, MRI, and gallium
scintigraphy .
Management is with steroid (prednisolone), disease
modifying anti-rheumatic drugs (DMARDS) and
vascular bypass surgery.
A 17 year old South African boy was referred from
vascular surgery clinic to the rheumatology clinic of
the Inkosi Albert Luthuli Central Hospital, Durban,
South Africa in October 2005 with a working
diagnosis of Takayasu's disease. He was being co-
managed by the cardiology clinic for heart failure
and vascular clinic for valvular heart disease for two
years before referral. His initial echocardiography
revealed significant aortic regurgitation and mild
mitral regurgitation.
He presented with generalized body weakness, left
anterior chest wall pain, fever, and joint pain
involving the knees and the elbows. He was still on
anti-failure drugs at the time of presentation. There
were no symptoms referable to the central nervous
system.
When examined, he was found to be small for age,
with temperature of 37.6 c, he had swollen and tender
left knee. The left radial artery was barely palpable
and a blood pressure difference of 30mmHg between
the two arms. Bruit was picked over the left axillary
region. A diagnosis of Takayasu's disease was made
by clinical and radiological assessment.
Unenhanced coronal magnetic resonant angiogram
revealed focal stenosis of the right external iliac
artery while the post contrast dynamic magnetic
angiogram revealed non-visualisation of the
proximal 3.5cm of the left subclavian artery from the
aortic arch. There was flow noted distally from the
level of the vertebral artery suggesting a retrograde
flow via the posterior circulation of the brain into the
left vertebral artery-subclavian steal. The right
vertebral artery was prominent. The left profunda
brachial artery was not visualized. All other arteries
were patent. The overall angiogram finding was
compatible with Takayasu's disease. Erythrocyte
sedimentation rate was 106mm/hr, PCV was 26%
and he had a leucocytosis of 14,300cells/mm .
He was placed initially on high dose prednisolone
which was tapered after two months when symptoms
had subsided. He is presently on 5mg prednisolone
daily. He however continued his visit to the
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immunosuppressive agents . This write-up is to
heighten the awareness of medical personnel of the
presence of this rare disease also in the black race.
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